Eton Pharmaceuticals, Inc

(NASDAQ:ETON)

Latest On Eton Pharmaceuticals, Inc (ETON):

Date/Time Type Description Signal Details
2023-05-11 19:30 ESTNewsEton Pharmaceuticals GAAP EPS of -$0.10 beats by $0.04, revenue of $5.3M beats by $0.74MN/A
2023-05-11 19:30 ESTNewsEton Pharmaceuticals, Inc. (ETON) Q1 2023 Earnings Call TranscriptN/A
2023-05-11 04:34 ESTNewsEton Pharmaceuticals Q1 2023 Earnings PreviewN/A
2023-03-20 12:57 ESTNewsEton Pharmaceuticals Has Some Potential As A Speculative PlayN/A
2023-03-17 08:31 ESTNewsEton Pharmaceuticals, Inc. (ETON) Q4 2022 Earnings Call TranscriptN/A
2023-03-16 17:33 ESTNewsEton Pharmaceuticals GAAP EPS of $0.04 beats by $0.03, revenue of $8.5M misses by $0.62MN/A
2023-03-16 02:22 ESTNewsEton Pharmaceuticals Q4 2022 Earnings PreviewN/A
2023-03-15 10:56 ESTNewsEton acquires Tulex's pediatric rare disease drug ET-600N/A
2023-01-11 09:58 ESTNewsEton says FDA accepted resubmitted NDA for methanol poisoning candidateN/A
2022-12-18 06:29 ESTNewsEton Pharmaceuticals: Alkindi Sprinkle Leads Growth In Orphan Disease PortfolioN/A
2022-11-11 09:37 ESTNewsEton Pharmaceuticals, Inc. (ETON) Q3 2022 Earnings Call TranscriptN/A
2022-11-10 16:33 ESTNewsEton Pharmaceuticals GAAP EPS of -$0.12, revenue of $3.22MN/A
2022-09-14 04:19 ESTNewsEton Pharmaceuticals acquires FDA-approved rare disease product betaine anhydrousN/A
2022-08-17 00:40 ESTNewsEton hits 52-week low on patent infringement ruling over generic Cysteine injectionN/A
2022-08-14 22:42 ESTNewsEton Pharmaceuticals: An Evolving 'Sum Of The Parts' StoryN/A
2022-08-12 18:52 ESTNewsEton Pharmaceuticals, Inc. (ETON) CEO Sean Brynjelsen on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-12 02:08 ESTNewsEton Pharmaceuticals GAAP EPS of -$0.06 misses by $0.09, revenue of $7.4M misses by $0.36MN/A
2022-08-11 09:11 ESTNewsEton Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-07-18 11:34 ESTNewsEton Pharma jumps 20% on FDA approval of seizure therapyN/A
2022-06-25 01:28 ESTNewsEton Pharmaceuticals sells hospital products to Dr. Reddy’s for up to $50MN/A
2022-05-27 19:52 ESTNewsEton Pharmaceuticals down 10% after hours following partner Complete Response LetterN/A
2022-05-17 06:20 ESTNewsEton Pharmaceuticals (ETON) Investor Presentation - SlideshowN/A
2022-05-13 12:51 ESTNewsEton Pharmaceuticals, Inc.'s (ETON) CEO Sean Brynjelsen on Q1 2021 Results - Earnings Call TranscriptN/A
2022-05-12 17:03 ESTNewsEton Pharmaceuticals GAAP EPS of -$0.21, revenue of $2.18MN/A
2022-05-11 22:56 ESTNewsEton Pharmaceuticals Q1 2022 Earnings PreviewN/A
2022-04-11 20:25 ESTNewsEton Pharma gains on FDA approval for Elcys genericN/A
2022-04-11 20:25 ESTNewsJames Gruber joins Eton Pharmaceuticals as CFON/A
2022-03-17 08:20 ESTNewsEton Pharmaceuticals GAAP EPS of $0.04 misses by $0.01, revenue of $6.09M misses by $1.47MN/A
2022-03-17 08:20 ESTNewsEton Pharmaceuticals, Inc. (ETON) CEO Sean Brynjelsen on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-15 23:30 ESTNewsEton Pharmaceuticals Q4 2021 Earnings PreviewN/A
2022-03-14 10:21 ESTNewsEton Pharmaceuticals, XGen launch low blood pressure drug RezipresN/A
2021-11-16 20:12 ESTNewsEton Pharmaceuticals, Inc. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-16 20:12 ESTNewsWarning: ETON is at high risk of performing badlyN/A
2021-11-16 00:39 ESTNewsEton Pharmaceuticals in pact with Tolmar to jointly promote ALKINDI SPRINKLEN/A
2021-11-16 00:37 ESTNewsEton Pharmaceuticals EPS misses by $0.10, misses on revenueN/A
2021-11-16 00:37 ESTNewsEton Pharmaceuticals' (ETON) CEO Sean Brynjelsen on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-08 11:19 ESTNewsEton Pharma granted FDA approval for seizure and migraine therapyN/A
2021-10-28 20:59 ESTNewsEton Pharma acquires marketing rights to generic version of CarbagluN/A
2021-09-03 15:13 ESTNewsAnother Look At Eton PharmaceuticalsN/A
2021-08-17 13:01 ESTNewsEton Pharmaceuticals, Inc. (ETON) CEO Sean Brynjelsen on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-16 17:26 ESTNewsEton Pharma urged to address misleading claims linked to Alkindi SprinkleN/A
2021-08-16 17:25 ESTNewsEton Pharmaceuticals EPS beats by $0.06, misses on revenueN/A
2021-08-15 22:48 ESTNewsEton Pharmaceuticals Q2 2021 Earnings PreviewN/A
2021-08-10 03:34 ESTNewsEton shares drop 18% on topiramate FDA action date delayN/A
2021-08-09 07:19 ESTNewsFDA decision on Eton's topiramate delayed to NovemberN/A
2021-08-06 23:12 ESTNewsMVST, MDRX, ETON and GDS among after hours moversN/A
2021-07-21 08:02 ESTNewsFDA declines to approve Eton Pharmaceuticals' methanol poisoning treatmentN/A
2021-07-21 07:47 ESTNewsStocks To Watch: FOMC Takes Center Stage, Hedge Funds Pitch And E3N/A
2021-07-21 07:44 ESTNewsEton Pharma wins FDA approval for RezipresN/A
2021-07-21 07:44 ESTNewsEton Pharmaceuticals acquires U.S. and Canadian rights to ZENEO hydrocortisone autoinjectorN/A

About Eton Pharmaceuticals, Inc (ETON):

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products. The company offers Biorphen, a phenylephrine hydrochloride injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia. It also develops EM-100, an ophthalmic product for the treatment of allergic conjunctivitis; ET-203, which is injectable product candidates for use in the hospital setting; ET-103, an oral liquid product candidate for hypothyroidism; ET-101 and ET-104, which are oral liquid product candidates for neurological indications; DS-300 and DS-100, which are injectable product candidates; and ET-105, a lamotrigine for oral suspension. Eton Pharmaceuticals, Inc. was founded in 2017 and is based in Deer Park, Illinois.

ETON Quotes by TradingView

See Advanced Chart

General

  • Name Eton Pharmaceuticals, Inc
  • Symbol ETON
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 17
  • Fiscal Year EndDecember
  • IPO Date2018-11-13
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.etonpharma.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 4320.52
  • Price/Book (Most Recent Quarter) 12.5
  • Enterprise Value Revenue 4656.31
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $0.24
  • Next Year EPS Estimate $0.30
  • Next Quarter EPS Estimate -$0.24
  • Operating Margin -69515%
  • Return on Assets -78%
  • Return on Equity -213%
  • Revenue 39000
  • Earnings Per Share -$3.07
  • Revenue Per Share $0
  • Gross Profit -247000
  • Quarterly Earnings Growth -82.4%
View More

Highlights

  • Market Capitalization 200.63 million
  • EBITDA -15345000
  • PE Ratio -17.77
  • Analyst Target Price $13.5
  • Book Value Per Share $0.64
View More

Share Statistics

  • Shares Outstanding 24.41 million
  • Shares Float 13.73 million
  • % Held by Insiders 2803%
  • % Held by Institutions 29.14%
  • Shares Short 788868
  • Shares Short Prior Month 807494
  • Short Ratio 4.72
  • Short % of Float 5%
  • Short % of Shares Outstanding 3%
View More

Technicals

  • Beta 1.23
  • 52 Week High $10.3
  • 52 Week Low $2.75
  • 50 Day Moving Average 8.8
  • 200 Day Moving Average 8.15
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Eton Pharmaceuticals, Inc (ETON) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Eton Pharmaceuticals, Inc (ETON) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312020-12-31$N/A-$0.32-$0.26-23.08%
2020-09-302020-11-12$-161000-$0.31-$0.25-22.38%
2020-06-302020-08-12$N/A-$0.23-$0.2611.54%
2020-03-312020-05-14$99000-$0.50-$0.22-123.91%
2019-12-312020-03-05$459000-$0.15-$0.2643.03%
2019-09-302019-11-14$N/A-$0.28-$0.25-13.5%
2019-06-302019-08-06$N/A-$0.18-$0.2834.55%
2019-03-312019-05-07$500000-$0.42
2018-12-312019-03-25$N/A-$2.24
2018-09-302018-12-20$N/A-$2.24

Eton Pharmaceuticals, Inc (ETON) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Eton Pharmaceuticals, Inc (ETON) Chart:

Eton Pharmaceuticals, Inc (ETON) News:

Below you will find a list of latest news for Eton Pharmaceuticals, Inc (ETON) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Eton Pharmaceuticals, Inc (ETON) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-05-162.511.9CALL0 231485.98TRUE00
2025-05-16511.35CALL5 8417.86TRUE11.350
2025-05-167.59.42CALL0 53212.86TRUE00
2025-05-16102.55CALL0 18117.18TRUE00
2025-05-1612.53.66CALL0 4696.53TRUE00
2025-05-16152CALL0 12566.94TRUE00
2025-05-1617.50.4CALL2 48363.03FALSE0.40
2025-05-16200.2CALL0 11160.13FALSE00
2025-05-1622.51.1CALL0 6143.55FALSE00
2025-05-16250.7CALL0 11213.32FALSE00
2025-05-16300.25CALL0 1256.61FALSE00
2025-05-16350.2CALL0 1290.46FALSE00
2025-05-162.50PUT0 0889.98FALSE00
2025-05-1650PUT0 0535.69FALSE00
2025-05-167.50.1PUT0 1373.85FALSE00
2025-05-16101.18PUT0 33265.4FALSE00
2025-05-1612.50.65PUT0 5499.15FALSE00
2025-05-16151.65PUT0 165.34FALSE00
2025-05-1617.50PUT0 0107.11TRUE00
2025-05-16205.9PUT0 993.88TRUE00
2025-05-1622.50PUT0 084.55TRUE00
2025-05-162512PUT0 2104.1TRUE00
2025-05-16300PUT0 0136.54TRUE00
2025-05-16350PUT0 0163.04TRUE00
2025-06-202.50CALL0 0922.59TRUE00
2025-06-2050CALL0 0136.3TRUE00
2025-06-207.50CALL0 079.51TRUE00
2025-06-20100CALL0 064.33TRUE00
2025-06-2012.50CALL0 077.51TRUE00
2025-06-20151.52CALL0 186.18TRUE00
2025-06-2017.50CALL0 094.89FALSE00
2025-06-20200CALL0 0108.35FALSE00
2025-06-2022.50CALL0 0120.69FALSE00
2025-06-20250CALL0 0133.09FALSE00
2025-06-202.50PUT0 0554.32FALSE00
2025-06-2050PUT0 0333.8FALSE00
2025-06-207.50PUT0 0233.17FALSE00
2025-06-20100PUT0 0165.78FALSE00
2025-06-2012.50PUT0 0120.84FALSE00
2025-06-20150PUT0 096.16FALSE00
2025-06-2017.50PUT0 091.64TRUE00
2025-06-20200PUT0 093.3TRUE00
2025-06-2022.50PUT0 091.51TRUE00
2025-06-20250PUT0 087.04TRUE00
2025-08-152.50CALL0 0654.58TRUE00
2025-08-15513.3CALL0 122327.87TRUE00
2025-08-157.510.15CALL0 574.84TRUE00
2025-08-15100CALL0 070.87TRUE00
2025-08-1512.52.5CALL0 2570.44TRUE00
2025-08-15153CALL0 2374.16TRUE00
2025-08-1517.51.2CALL0 3867.73FALSE00
2025-08-15203.21CALL0 2584.94FALSE00
2025-08-1522.52.05CALL0 192.79FALSE00
2025-08-15250.75CALL0 3299.63FALSE00
2025-08-15300.5CALL0 32112.14FALSE00
2025-08-15350.2CALL0 2124.27FALSE00
2025-08-152.50PUT0 0395.3FALSE00
2025-08-1550PUT0 0238.2FALSE00
2025-08-157.50.22PUT0 3168.25FALSE00
2025-08-15100PUT0 0124.81FALSE00
2025-08-1512.51.75PUT0 2796.26FALSE00
2025-08-15152.5PUT0 384.06FALSE00
2025-08-1517.53.6PUT0 181.15TRUE00
2025-08-15200PUT0 077.82TRUE00
2025-08-1522.50PUT0 082.35TRUE00
2025-08-15250PUT0 085.99TRUE00
2025-08-15300PUT0 071.9TRUE00
2025-08-15350PUT0 085.67TRUE00
2025-11-212.50CALL0 0478.22TRUE00
2025-11-2150CALL0 0245.49TRUE00
2025-11-217.50CALL0 069.48TRUE00
2025-11-21105.5CALL0 1562.42TRUE00
2025-11-2112.50CALL0 072.48TRUE00
2025-11-21150CALL0 073.42TRUE00
2025-11-2117.52.6CALL0 176.52FALSE00
2025-11-21200CALL0 074.79FALSE00
2025-11-2122.50CALL0 076.84FALSE00
2025-11-21250CALL0 081.84FALSE00
2025-11-21300CALL0 0113.51FALSE00
2025-11-212.50PUT0 0294.7FALSE00
2025-11-2150.3PUT0 2180.81FALSE00
2025-11-217.50.42PUT0 1125.55FALSE00
2025-11-21100PUT0 0101.33FALSE00
2025-11-2112.50PUT0 084FALSE00
2025-11-21150PUT0 082.4FALSE00
2025-11-2117.50PUT0 084.1TRUE00
2025-11-21200PUT0 080.86TRUE00
2025-11-2122.50PUT0 081.52TRUE00
2025-11-21250PUT0 079.18TRUE00
2025-11-21300PUT0 079.06TRUE00

Latest ETON Trades:

Date Shares Price
Jun 13, 2022 5:36 PM EST2$2.885
Jun 13, 2022 5:47 PM EST4$2.885
Jun 13, 2022 6:38 PM EST13$2.9
Jun 13, 2022 7:24 PM EST100$2.9
Jun 13, 2022 7:25 PM EST100$2.86

Eton Pharmaceuticals, Inc (ETON) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315220010937/0001493152-20-010937-index.htm
2019-12-10UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1710340/000000000019016252/0000000000-19-016252-index.htm
2020-05-05UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1710340/000000000020003885/0000000000-20-003885-index.htm
2020-05-27UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1710340/000000000020004688/0000000000-20-004688-index.htm
2020-08-04UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1710340/000000000020007104/0000000000-20-007104-index.htm
2018-11-21SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1710340/000089914018000602/0000899140-18-000602-index.htm
2018-11-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1710340/000120919118058316/0001209191-18-058316-index.htm
2018-11-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1710340/000120919118058318/0001209191-18-058318-index.htm
2018-11-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1710340/000120919118058320/0001209191-18-058320-index.htm
2018-11-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1710340/000120919118058321/0001209191-18-058321-index.htm
2018-11-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1710340/000120919118058324/0001209191-18-058324-index.htm
2018-11-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1710340/000120919118058325/0001209191-18-058325-index.htm
2018-11-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1710340/000120919118058821/0001209191-18-058821-index.htm
2018-11-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1710340/000120919118058822/0001209191-18-058822-index.htm
2018-11-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1710340/000120919118058824/0001209191-18-058824-index.htm
2018-11-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1710340/000120919118058825/0001209191-18-058825-index.htm
2018-11-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1710340/000120919118058826/0001209191-18-058826-index.htm
2018-11-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1710340/000120919118058827/0001209191-18-058827-index.htm
2019-03-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1710340/000120919119018103/0001209191-19-018103-index.htm
2019-03-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1710340/000120919119018106/0001209191-19-018106-index.htm
2019-03-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1710340/000120919119018109/0001209191-19-018109-index.htm
2019-03-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1710340/000120919119018114/0001209191-19-018114-index.htm
2019-03-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1710340/000120919119018118/0001209191-19-018118-index.htm
2019-03-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1710340/000120919119018122/0001209191-19-018122-index.htm
2019-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1710340/000120919119032054/0001209191-19-032054-index.htm
2019-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1710340/000120919119045498/0001209191-19-045498-index.htm
2019-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1710340/000120919119045738/0001209191-19-045738-index.htm
2018-11-08CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1710340/000135445718000454/0001354457-18-000454-index.htm
2017-06-28DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1710340/000149315217007275/0001493152-17-007275-index.htm
2018-11-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1710340/000149315218015806/0001493152-18-015806-index.htm
2018-11-23SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1710340/000149315218016669/0001493152-18-016669-index.htm
2018-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315218017722/0001493152-18-017722-index.htm
2018-12-2010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1710340/000149315218017724/0001493152-18-017724-index.htm
2019-01-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315219000907/0001493152-19-000907-index.htm
2019-02-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315219001663/0001493152-19-001663-index.htm
2019-02-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1710340/000149315219001718/0001493152-19-001718-index.htm
2019-02-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315219002230/0001493152-19-002230-index.htm
2019-03-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315219003813/0001493152-19-003813-index.htm
2019-03-2510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1710340/000149315219003817/0001493152-19-003817-index.htm
2019-03-28S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1710340/000149315219004108/0001493152-19-004108-index.htm
2019-04-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1710340/000149315219006004/0001493152-19-006004-index.htm
2019-04-26DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1710340/000149315219006005/0001493152-19-006005-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315219006515/0001493152-19-006515-index.htm
2019-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1710340/000149315219006526/0001493152-19-006526-index.htm
2019-05-24SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1710340/000149315219008254/0001493152-19-008254-index.htm
2019-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315219009066/0001493152-19-009066-index.htm
2019-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315219009127/0001493152-19-009127-index.htm
2019-07-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315219010573/0001493152-19-010573-index.htm
2019-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315219011467/0001493152-19-011467-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315219011725/0001493152-19-011725-index.htm
2019-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1710340/000149315219011727/0001493152-19-011727-index.htm
2019-08-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315219012932/0001493152-19-012932-index.htm
2019-10-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315219015787/0001493152-19-015787-index.htm
2019-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315219017479/0001493152-19-017479-index.htm
2019-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1710340/000149315219017499/0001493152-19-017499-index.htm
2019-12-02S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1710340/000149315219018638/0001493152-19-018638-index.htm
2019-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315219018669/0001493152-19-018669-index.htm
2019-12-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315219019062/0001493152-19-019062-index.htm
2019-12-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1710340/000149315219019077/0001493152-19-019077-index.htm
2020-01-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315220000810/0001493152-20-000810-index.htm
2020-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1710340/000149315220001575/0001493152-20-001575-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1710340/000149315220002532/0001493152-20-002532-index.htm
2020-02-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315220002695/0001493152-20-002695-index.htm
2020-03-0510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1710340/000149315220003451/0001493152-20-003451-index.htm
2020-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315220003486/0001493152-20-003486-index.htm
2020-03-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1710340/000149315220004052/0001493152-20-004052-index.htm
2020-03-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1710340/000149315220004053/0001493152-20-004053-index.htm
2020-03-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1710340/000149315220004056/0001493152-20-004056-index.htm
2020-03-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1710340/000149315220004058/0001493152-20-004058-index.htm
2020-03-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1710340/000149315220004059/0001493152-20-004059-index.htm
2020-03-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1710340/000149315220004062/0001493152-20-004062-index.htm
2020-03-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315220004113/0001493152-20-004113-index.htm
2020-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315220004191/0001493152-20-004191-index.htm
2020-03-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315220005035/0001493152-20-005035-index.htm
2020-03-30424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1710340/000149315220005038/0001493152-20-005038-index.htm
2020-04-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1710340/000149315220005927/0001493152-20-005927-index.htm
2020-04-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1710340/000149315220005929/0001493152-20-005929-index.htm
2020-04-08DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1710340/000149315220006039/0001493152-20-006039-index.htm
2020-04-22DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1710340/000149315220006934/0001493152-20-006934-index.htm
2020-04-22DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1710340/000149315220006939/0001493152-20-006939-index.htm
2020-05-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315220007595/0001493152-20-007595-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315220007843/0001493152-20-007843-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315220007957/0001493152-20-007957-index.htm
2020-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315220008752/0001493152-20-008752-index.htm
2020-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1710340/000149315220008763/0001493152-20-008763-index.htm
2020-05-15CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1710340/000149315220009223/0001493152-20-009223-index.htm
2020-05-2110-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1710340/000149315220009627/0001493152-20-009627-index.htm
2020-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315220010937/0001493152-20-010937-index.htm
2020-07-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315220014011/0001493152-20-014011-index.htm
2020-07-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315220014213/0001493152-20-014213-index.htm
2020-07-31S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1710340/000149315220014330/0001493152-20-014330-index.htm
2020-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315220014335/0001493152-20-014335-index.htm
2020-08-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315220015198/0001493152-20-015198-index.htm
2020-08-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315220015303/0001493152-20-015303-index.htm
2020-08-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1710340/000149315220015336/0001493152-20-015336-index.htm
2020-08-24CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1710340/000149315220016594/0001493152-20-016594-index.htm
2020-08-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315220016975/0001493152-20-016975-index.htm
2020-09-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315220017873/0001493152-20-017873-index.htm
2020-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315220018322/0001493152-20-018322-index.htm
2020-09-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315220018576/0001493152-20-018576-index.htm
2020-10-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315220019035/0001493152-20-019035-index.htm
2020-10-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315220019121/0001493152-20-019121-index.htm
2020-10-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1710340/000149315220019347/0001493152-20-019347-index.htm
2020-10-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315220019406/0001493152-20-019406-index.htm
2020-10-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315220019467/0001493152-20-019467-index.htm
2020-10-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1710340/000149315220019503/0001493152-20-019503-index.htm
2020-10-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000149315220019583/0001493152-20-019583-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1710340/000149315220019587/0001493152-20-019587-index.htm
2018-03-20DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1710340/000161577418002013/0001615774-18-002013-index.htm
2018-06-28DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1710340/000161577418005879/0001615774-18-005879-index.htm
2018-08-10S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1710340/000161577418007833/0001615774-18-007833-index.htm
2018-09-25S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1710340/000161577418009956/0001615774-18-009956-index.htm
2018-09-28FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1710340/000161577418010167/0001615774-18-010167-index.htm
2018-10-18S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1710340/000161577418011027/0001615774-18-011027-index.htm
2018-10-31S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1710340/000161577418011677/0001615774-18-011677-index.htm
2018-11-05S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1710340/000161577418012090/0001615774-18-012090-index.htm
2018-11-088-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1710340/000161577418012296/0001615774-18-012296-index.htm
2018-11-13424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1710340/000161577418012575/0001615774-18-012575-index.htm
2018-11-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1710340/000161577418013052/0001615774-18-013052-index.htm
2018-11-20S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1710340/000161577418013060/0001615774-18-013060-index.htm
2018-11-09EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1710340/999999999518002850/9999999995-18-002850-index.htm
2019-12-16EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1710340/999999999519002824/9999999995-19-002824-index.htm
2020-08-25EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1710340/999999999520002245/9999999995-20-002245-index.htm
2018-11-09CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1710340/999999999718008960/9999999997-18-008960-index.htm

Eton Pharmaceuticals, Inc (ETON) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Eton Pharmaceuticals, Inc (ETON). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 2803%
Institutional Ownership: 2914%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-11-15MARK L BAUMDirectorBuy10,000.006.0060,000.0010,000.00https://www.sec.gov/Archives/edgar/data/1710340/000120919118058821/0001209191-18-058821-index.htm
2018-11-15SEAN BRYNJELSENPresident & CEOBuy10,000.006.0060,000.001,010,000.00https://www.sec.gov/Archives/edgar/data/1710340/000120919118058826/0001209191-18-058826-index.htm
2019-05-20SEAN BRYNJELSENPresident & CEOBuy1,400.007.7810,894.801,011,400.00https://www.sec.gov/Archives/edgar/data/1710340/000120919119032054/0001209191-19-032054-index.htm
2019-05-21SEAN BRYNJELSENPresident & CEOBuy8,600.007.9668,431.061,020,000.00https://www.sec.gov/Archives/edgar/data/1710340/000120919119032054/0001209191-19-032054-index.htm
2019-08-13SEAN BRYNJELSENPresident & CEOBuy5,000.006.1530,750.001,025,000.00https://www.sec.gov/Archives/edgar/data/1710340/000120919119045738/0001209191-19-045738-index.htm
2020-10-16Opaleye Management Inc.10% Share HolderBuy15,000.007.00105,000.00155,000.00https://www.sec.gov/Archives/edgar/data/1710340/000149315220019587/0001493152-20-019587-index.htm
2020-10-16Opaleye Management Inc.10% Share HolderBuy385,000.007.002,695,000.003,885,000.00https://www.sec.gov/Archives/edgar/data/1710340/000149315220019587/0001493152-20-019587-index.htm
2018-11-15William Wilson TroutmanCFO, Treasurer & SecretaryBuy5,000.006.0030,000.005,000.00https://www.sec.gov/Archives/edgar/data/1710340/000120919118058822/0001209191-18-058822-index.htm
2018-11-15NORBERT G RIEDELDirectorBuy5,000.006.0030,000.0059,745.00https://www.sec.gov/Archives/edgar/data/1710340/000120919118058824/0001209191-18-058824-index.htm
2018-11-15PAUL V MAIERDirectorBuy5,000.006.0030,000.0059,745.00https://www.sec.gov/Archives/edgar/data/1710340/000120919118058825/0001209191-18-058825-index.htm
2018-11-15CHARLES J CASAMENTODirectorBuy5,000.006.0030,000.0068,420.00https://www.sec.gov/Archives/edgar/data/1710340/000120919118058827/0001209191-18-058827-index.htm
2019-08-09CHARLES J CASAMENTODirectorBuy3,500.006.1121,369.9571,920.00https://www.sec.gov/Archives/edgar/data/1710340/000120919119045498/0001209191-19-045498-index.htm